jshort, Author at Sanford Burnham Prebys - Page 7 of 13
Institute News

Researchers find new method to halt the advance of liver cancer

Authorsgammon
Date

July 24, 2015

A new study by researchers at SBP, the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the lymphotoxin-beta receptor (LTβR), reduces the progression of liver cancer. The results, published recently in the online edition of Gut, could provide new treatment strategies for the disease, which is the third leading cause of cancer-related deaths worldwide. Continue reading “Researchers find new method to halt the advance of liver cancer”

Institute News

Potential drug targets could improve treatment of vascular disease in diabetic patients

Authorsgammon
Date

July 15, 2015

The newly discovered role of a vascular protein in diabetes-induced hardening of the arteries could lead to better treatments that reduce the risk of heart attack, stroke, and death, according to research spearheaded by SBP investigators. The study, published recently in Circulation Research, reveals that a receptor called LRP6 inhibits molecular signals that drive diet-induced hardening of the arteries, also known as arteriosclerosis. Continue reading “Potential drug targets could improve treatment of vascular disease in diabetic patients”

Institute News

Newly identified cause of motor neuron disease paves way for better treatments

Authorsgammon
Date

July 8, 2015

The discovery that a protein called membralin promotes the survival of motor neurons could potentially lead to novel therapies for severe, early-onset motor neuron disease, according to a recent study by SBP investigators. As reported recently in eLife, the researchers developed a novel mouse model for identifying therapeutic targets for a class of motor neuron disorders called distal hereditary motor neuropathies. Continue reading “Newly identified cause of motor neuron disease paves way for better treatments”

Institute News

Run Noah run

Authorsgammon
Date

July 1, 2015

On Saturday, July 4, at 3 p.m., an extraordinary man named Noah Coughlan will complete a run—a solo run— that stretched more than 3,000 miles and 13 states. His journey will have lasted 127 days. Even more impressive is that this is the third time he has done it. Why on earth would someone take on such a feat? Continue reading “Run Noah run”

Institute News

New drug squashes cancer’s last-ditch efforts to survive

Authorsgammon
Date

June 25, 2015

As a tumor grows, its cancerous cells ramp up an energy-harvesting process to support its hasty development. This process, called autophagy, is normally used by a cell to recycle damaged organelles and proteins, but is also co-opted by cancer cells to meet their increased energy and metabolic demands. Continue reading “New drug squashes cancer’s last-ditch efforts to survive”

Institute News

How arsenic cures leukemia

Authorsgammon
Date

June 18, 2015

For the first time, Sanford-Burnham researchers have shown how the reversible interactions of the small protein SUMO work to facilitate treatment of acute promyelocytic leukemia (APL). The study, published recently in the journal Science Signaling, explains how the on-off associations of SUMO are required to destroy the APL causing oncoprotein and pave the way for an arsenic-based cure. Continue reading “How arsenic cures leukemia”

Institute News

2015 Sanford-Burnham faculty retreat

Authorsgammon
Date

June 5, 2015

The annual Sanford-Burnham faculty retreat was held in beautiful Carlsbad, Calif., May 19-20. Attended by more than 70 faculty from La Jolla, Calif., and Lake Nona, Fla., the retreat was an opportunity for attendees to learn more about each other’s research, share ideas, and to engage in strategic discussions related to the Institute’s 10-year vision to become a preeminent medical research institute that combines cutting-edge fundamental research with robust drug discovery. Continue reading “2015 Sanford-Burnham faculty retreat”

Institute News

Research offers a new approach to improving HIV vaccines

Authorsgammon
Date

June 4, 2015

In a scientific discovery that has significant implications for preventing HIV infections, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have identified a protein that could improve the body’s immune response to HIV vaccines and prevent transmission of the virus. Continue reading “Research offers a new approach to improving HIV vaccines”

Institute News

Stem cell model reveals molecular cues critical to neurovascular unit formation

Authorsgammon
Date

June 1, 2015

Crucial bodily functions we depend on but don’t consciously think about — things like heart rate, blood flow, breathing, and digestion — are regulated by the neurovascular unit. The neurovascular unit is made up of blood vessels and smooth muscles under the control of autonomic neurons. Yet how the nervous and vascular systems come together during development to coordinate these functions is not well understood. Using human embryonic stem cells, researchers at Sanford-Burnham, University of California, San Diego School of Medicine, and Moores Cancer Center created a model that allows them to track cellular behavior during the earliest stages of human development in real-time. The model reveals, for the first time, how autonomic neurons and blood vessels come together to form the neurovascular unit. The study was published May 21 by Stem Cell Reports. Continue reading “Stem cell model reveals molecular cues critical to neurovascular unit formation”

Institute News

Novel model for cardiomyopathy paves the way for new therapies

Authorsgammon
Date

May 29, 2015

A new fruit fly model that captures key metabolic defects associated with cardiomyopathy could translate into more-effective treatments for this potentially deadly heart condition, according to a study conducted by researchers at Sanford-Burnham and the Universidad Autónoma de Madrid in Spain. The findings, published April 9 in Human Molecular Genetics, could also have broader clinical implications for human metabolic diseases affecting other organ systems such as the liver and skeletal muscle. Continue reading “Novel model for cardiomyopathy paves the way for new therapies”